IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $38,501,000 | +24.3% | 1,979,464 | +6.4% | 0.65% | +22.9% |
| Q4 2017 | $30,968,000 | +103.0% | 1,859,924 | +147.5% | 0.53% | +108.3% |
| Q3 2017 | $15,257,000 | +25.5% | 751,576 | -0.4% | 0.25% | +21.0% |
| Q2 2017 | $12,153,000 | +23.6% | 754,865 | -2.9% | 0.21% | +13.5% |
| Q1 2017 | $9,830,000 | -1.6% | 777,095 | +3.1% | 0.18% | -4.6% |
| Q4 2016 | $9,990,000 | -53.2% | 753,953 | -16.3% | 0.19% | -51.6% |
| Q3 2016 | $21,340,000 | -19.3% | 900,433 | -1.8% | 0.40% | -26.6% |
| Q2 2016 | $26,437,000 | +6.7% | 917,323 | +18.5% | 0.55% | -0.5% |
| Q1 2016 | $24,783,000 | +1179.5% | 773,973 | +1608.7% | 0.55% | +1120.0% |
| Q4 2015 | $1,937,000 | +25.2% | 45,295 | +3.1% | 0.04% | +21.6% |
| Q3 2015 | $1,547,000 | +0.8% | 43,945 | +31.5% | 0.04% | +5.7% |
| Q2 2015 | $1,535,000 | -4.0% | 33,420 | -2.0% | 0.04% | -2.8% |
| Q1 2015 | $1,599,000 | – | 34,115 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 730,817 | $21,062,000 | 7.59% |
| Hound Partners | 6,757,558 | $194,753,000 | 5.18% |
| Aravt Global | 2,232,500 | $64,341,000 | 4.78% |
| Asymmetry Capital Management, L.P. | 70,235 | $2,024,000 | 3.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 66,091 | $1,905,000 | 1.80% |
| Orbimed Advisors | 5,886,700 | $169,655,000 | 1.77% |
| Pennant Capital Management, LLC | 1,949,569 | $56,187,000 | 1.44% |
| SECTOR GAMMA AS | 233,934 | $6,742,000 | 1.28% |
| Tygh Capital Management, Inc. | 137,190 | $3,954,000 | 1.11% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 555,086 | $15,998,000 | 0.93% |